Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular evolutionary patterns in breast cancer.

Stanley E Shackney1, Jan F Silverman

  • 1Department of Human Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA. shakney@wpahs.org

Advances in Anatomic Pathology
|September 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pleural Effusion Cytology of Metastatic Sclerosing Epithelioid Fibrosarcoma.

Diagnostic cytopathology·2026
Same author

Neutrophil Cannibalism by Tumor Cells in Squamous Cell Carcinoma: Cytologic Features and Clinical Implications.

Diagnostic cytopathology·2025
Same author

Diagnostic challenges of the neurofibroma-malignant peripheral nerve sheath tumor spectrum in neurofibromatosis type 1: illustrative case.

Journal of neurosurgery. Case lessons·2025
Same author

Analyzing the impact of molecular testing on the cytological diagnosis of thyroid nodules: Insights from our institution's experience.

Cancer cytopathology·2025
Same author

Fine Needle Aspiration Cytology of Metastatic Endolymphatic Sac Tumor: A Case Report.

Diagnostic cytopathology·2025
Same author

Primary Osseous Low-Grade Myxofibrosarcoma of Clavicle Presenting With Multiple Skeletal Metastases.

Cureus·2020
Same journal

Pathobiology and Interactions of the MiTF Signaling Pathways.

Advances in anatomic pathology·2026
Same journal

Diagnosis and Reporting of Intraductal Carcinoma of the Prostate: A Guide for Practising Pathologists With Excerpts From the Genitourinary Pathology Society and the International Society of Urological Pathology Joint Expert Consultation.

Advances in anatomic pathology·2026
Same journal

An Update on Soft Tissue Tumors of the Paratesticular Region.

Advances in anatomic pathology·2026
Same journal

Recognizing Familial Thyroid Neoplasia: The Pathologist's Role in Diagnosis and Management.

Advances in anatomic pathology·2026
Same journal

Hereditary and Familial Tumor Syndromes: When to Think of Them? The Emerging Role of Pathologists as Sentinels of Genetic Cancer Predisposition.

Advances in anatomic pathology·2026
Same journal

From Familial Clustering to a Dedicated Classification: The Historical Recognition of Hereditary Tumor Syndromes in the WHO Classification of Tumors.

Advances in anatomic pathology·2026
See all related articles

Lobular breast cancers often have E-cadherin gene mutations, unlike ductal carcinomas. Similarities exist between lobular and low-grade ductal cancers, while high-grade ductal cancers show distinct genetic changes like p53 dysfunction.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer comprises various subtypes with distinct molecular and phenotypic characteristics.
  • Understanding the genetic underpinnings of different breast cancer types is crucial for targeted therapies.

Purpose of the Study:

  • To review and compare the geno-phenotypic patterns of lobular breast cancers (LBC) and infiltrating ductal carcinomas (IDC) of varying grades.
  • To identify key molecular differences and similarities that inform breast cancer progression models.

Main Methods:

  • Review of existing literature on the genetic and phenotypic profiles of LBC and IDC.
  • Comparative analysis of gene mutations (e.g., E-cadherin, p53, Her-2/neu, ras) and protein expression patterns.

Related Experiment Videos

Main Results:

  • Inactivating E-cadherin gene mutations are a key differentiator for LBC.
  • LBC and low-grade IDC share similar geno-phenotypic profiles.
  • p53 dysfunction is associated with intermediate and high-grade IDC, while Her-2/neu, ras, and Rb dysfunctions define aggressive subsets.

Conclusions:

  • A branching molecular evolutionary model is proposed for breast cancer development and progression.
  • Distinct genetic alterations characterize different subtypes and grades of breast cancer, guiding therapeutic strategies.